3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
2
Status
Completed
2
Sponsor Class
INDUSTRY
2
OTHER_GOV
1
OTHER
1
Study Type
Interventional
2
Sponsor
Conditions
Arthritis, Rheumatoid
6
Spondylitis, Ankylosing
2
Psoriasis
2
Crohn Disease
2
Colitis, Ulcerative
2
Uveal Melanoma
1
Plaque Psoriasis
1
Melanoma
1
Hidradenitis Suppurativa
1
Healthy Adult Male
1
Healthy
1
Acne Vulgaris
1
Abscess
1
Interventions
etrolizumab
5
Infliximab
3
Adalimumab
2
peficitinib
1
golimumab
1
NX-13
1
Methylprednisolone
1
Mesalamine
1
Injections
1
CT-P13
1
Andrographis paniculata extract
1
ABX464
1
2-(3',4'-dihydroxyphenyl-1-azo)benzimidazole
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
INDUSTRY
×
Colitis, Ulcerative
×
Adalimumab
×
Clear all
NCT02163759
2021-07-23
HIBISCUS I
Hoffmann-La Roche
Phase 3
Completed
358 enrolled
42 charts
NCT02171429
2021-07-23
HIBISCUS II
Hoffmann-La Roche
Phase 3
Completed
358 enrolled
38 charts